Prognostic factors in non-small cell lung cancer patients and prognostic importance of PET/CT SUV max value

Basit Öğe Kaydı
dc.contributor.authorErdem, Vedat
dc.contributor.authorSen, Hatice Selimoglu
dc.contributor.authorKomek, Halil
dc.contributor.authorTanrikulu, A. Cetin
dc.contributor.authorAbakay, Abdurrahman
dc.contributor.authorSezgi, Cengizhan
dc.contributor.authorKaya, Halide
dc.date.accessioned2024-04-24T17:27:54Z
dc.date.available2024-04-24T17:27:54Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractIntroduction: This study planned to investigate the maximum standard uptake values (SUV max) at fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) whether associated with survival or not and the effect of demographic, clinical and laboratory data on survival in non-small cell lung cancer (NSCLC) patients. Materials and Methods: This study was created by examining retrospectively the records of 101 patients with NSCLC that received a definitive diagnosis and FDG-PET/CT used for staging in our center between May 2006-March 2011. Especially FDG-PET/CT, SUV max and the other clinical, histopathologic, laboratory and treatment parameters that effects prognosis were recorded and statistical analysis was performed. Results: Eighty eight (87.1%) of the patients were men and 13 (12.9%) were women. The average survival period was 10.6 +/- 8.5 (1-49 months) months. The demographic, clinical, laboratory and radiological parameters were divided into two groups with the median value of SUV max (12.0). There was not a significant difference in survival between the two groups (p= 0.807). The study showed that advanced stage, presence of metastasis, high lactate dehydrogenase (LDH) levels, high white blood cell levels, inoperability, low albumin levels and low performance effect negative on survival. Conclusion: It was considered that SUV max does not play an important role in the survival period of NSCLC patients. Knowledge of performance condition, serum LDH, leukocyte and albumin values may provide a better prognostic evaluation.en_US
dc.identifier.doi10.5578/tt.3062
dc.identifier.endpage217en_US
dc.identifier.issn0494-1373
dc.identifier.issue3en_US
dc.identifier.pmid23030745
dc.identifier.scopus2-s2.0-84867170722
dc.identifier.scopusqualityQ3
dc.identifier.startpage207en_US
dc.identifier.urihttps://doi.org/10.5578/tt.3062
dc.identifier.urihttps://hdl.handle.net/11468/20250
dc.identifier.volume60en_US
dc.identifier.wosWOS:000421306400002
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isotren_US
dc.publisherTurkish Assoc Tuberculosis & Thoraxen_US
dc.relation.ispartofTuberkuloz Ve Torak-Tuberculosis and Thorax
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNon-Small Cell Lung Canceren_US
dc.subjectPrognostic Factoren_US
dc.subjectSuv Maxen_US
dc.titlePrognostic factors in non-small cell lung cancer patients and prognostic importance of PET/CT SUV max valueen_US
dc.titlePrognostic factors in non-small cell lung cancer patients and prognostic importance of PET/CT SUV max value
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu